228 related articles for article (PubMed ID: 31848497)
1. [Significance of anti-carbamylated fibrinogen antibodies in systemic lupus erythematosus].
Li YN; Xiang XH; Zhao J; Li Y; Sun F; Wang HY; Jia RL; Hu FL
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1019-1024. PubMed ID: 31848497
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity.
Li Y; Jia R; Liu Y; Tang S; Ma X; Shi L; Zhao J; Hu F; Li Z
Lupus; 2020 Mar; 29(3):239-247. PubMed ID: 31930936
[TBL] [Abstract][Full Text] [Related]
3. [Significance of IgA isotype of anti-v-raf murine sarcoma viral oncogene homologue B1 antibody in rheumatoid arthritis].
Jin YJ; Sun L; Zhao JX; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):631-635. PubMed ID: 37534643
[TBL] [Abstract][Full Text] [Related]
4. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
[TBL] [Abstract][Full Text] [Related]
5. [Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease].
Zhu H; Zhao LJ; Zhou Y; Chen Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1003-1007. PubMed ID: 31848494
[TBL] [Abstract][Full Text] [Related]
6. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
[TBL] [Abstract][Full Text] [Related]
7. [Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis].
Jin YJ; Sun L; Yang L; Xing R; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):947-950. PubMed ID: 27987495
[TBL] [Abstract][Full Text] [Related]
8. Anti-carbamylated protein antibodies positivity and disease activity in Hispanic patients with established rheumatoid arthritis: An observational study.
Vega-Morales D; Garza-Elizondo MA; Trouw LA; Gonzalez-Torres KI; Torres-Lopez E; Eguia-Bernal M; Loredo-Alanis SA; Gracia-Arechiga TS; Vazquez-Fuentes BR; Castañeda-Martinez DD; Castañeda-Martinez MM; Elizondo-Solis CV; Mendiola-Jimenez A; Salinas-Carmona MC; Herrera-Sandate P; la Garza JAC; Rodriguez-Sanchez GE; Galarza-Delgado DA
Mod Rheumatol; 2022 Feb; 32(2):330-337. PubMed ID: 33853472
[TBL] [Abstract][Full Text] [Related]
9. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
10. Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus.
Meng Y; Zhang M; Zhao X; Cheng Y; Jia R; Wang Y; Sun X
Clin Rheumatol; 2018 Oct; 37(10):2707-2714. PubMed ID: 29998369
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of anti-carbamylated protein antibody in patients with rheumatoid arthritis: association with disease activity and bone destruction.
Zhang B; Lei Y; Li X; Gao Z; Xia L; Lu J; Shen H
J Investig Med; 2020 Aug; 68(6):1186-1192. PubMed ID: 32690598
[TBL] [Abstract][Full Text] [Related]
14. Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study Group.
Witte T; Hartung K; Matthias T; Sachse C; Fricke M; Deicher H; Kalden JR; Lakomek HJ; Peter HH; Schmidt RE
Rheumatol Int; 1998; 18(2):63-9. PubMed ID: 9782535
[TBL] [Abstract][Full Text] [Related]
15. Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement.
Massaro L; Ceccarelli F; Colasanti T; Pendolino M; Perricone C; Cipriano E; Natalucci F; Capalbo G; Lucchetti R; Pecani A; Vomero M; Mancini R; Spinelli FR; Alessandri C; Valesini G; Conti F
Lupus; 2018 Jan; 27(1):105-111. PubMed ID: 28592200
[TBL] [Abstract][Full Text] [Related]
16. Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus.
Ceccarelli F; Perricone C; Colasanti T; Massaro L; Cipriano E; Pendolino M; Natalucci F; Mancini R; Spinelli FR; Valesini G; Conti F; Alessandri C
Arthritis Res Ther; 2018 Jun; 20(1):126. PubMed ID: 29898764
[TBL] [Abstract][Full Text] [Related]
17. Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus.
Li J; Shen Y; He J; Jia R; Wang X; Chen X; Wang D; Han L; Zhu L; Chi X; Saschenbrecker S; Dähnrich C; Stöcker W; Schlumberger W; Li ZG
J Clin Lab Anal; 2013 Mar; 27(2):87-95. PubMed ID: 23400861
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and application of quantitative detection of serum anti-carbamylated protein autoantibodies by microarray chemiluminescence immunoassay].
Yao X; Xue M; Gui T; Ma C; Jiang X; Yan H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct; 34(10):924-930. PubMed ID: 30554586
[TBL] [Abstract][Full Text] [Related]
19. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
20. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
